Until 2000? Glycopeptides used to be the last effective line of defense for cases of Methicillin-resistant Staphylococcus aureus, however several newer classes of antibiotics have proven to have activity against MRSA, including, in 2000, linezolid of the oxazolidinone class, and in 2003 daptomycin of the lipopeptide class.